instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | The Role of Non-Selective TNF Inhibitors in Demyelinating Events.
The use of non-selective tumor necrosis factor (TNF) inhibitors is well known in the treatment of inflammatory diseases such as rheumatoid arthritis, Crohn's disease, and psoriasis. Its use in neurological disorders is limited however, due to rare advers... | INFLIXIMAB, METHOTREXATE, RITUXIMAB, SECUKINUMAB | DrugsGivenReaction | CC BY | 33401396 | 18,749,761 | 2021-01-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Demyelination'. | The Role of Non-Selective TNF Inhibitors in Demyelinating Events.
The use of non-selective tumor necrosis factor (TNF) inhibitors is well known in the treatment of inflammatory diseases such as rheumatoid arthritis, Crohn's disease, and psoriasis. Its use in neurological disorders is limited however, due to rare advers... | INFLIXIMAB, METHOTREXATE, RITUXIMAB, SECUKINUMAB | DrugsGivenReaction | CC BY | 33401396 | 18,783,118 | 2021-01-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Psoriatic arthropathy'. | The Role of Non-Selective TNF Inhibitors in Demyelinating Events.
The use of non-selective tumor necrosis factor (TNF) inhibitors is well known in the treatment of inflammatory diseases such as rheumatoid arthritis, Crohn's disease, and psoriasis. Its use in neurological disorders is limited however, due to rare advers... | INFLIXIMAB, METHOTREXATE, RITUXIMAB, SECUKINUMAB | DrugsGivenReaction | CC BY | 33401396 | 18,871,003 | 2021-01-01 |
What was the administration route of drug 'INFLIXIMAB'? | The Role of Non-Selective TNF Inhibitors in Demyelinating Events.
The use of non-selective tumor necrosis factor (TNF) inhibitors is well known in the treatment of inflammatory diseases such as rheumatoid arthritis, Crohn's disease, and psoriasis. Its use in neurological disorders is limited however, due to rare advers... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33401396 | 18,783,118 | 2021-01-01 |
What was the dosage of drug 'INFLIXIMAB'? | The Role of Non-Selective TNF Inhibitors in Demyelinating Events.
The use of non-selective tumor necrosis factor (TNF) inhibitors is well known in the treatment of inflammatory diseases such as rheumatoid arthritis, Crohn's disease, and psoriasis. Its use in neurological disorders is limited however, due to rare advers... | UNK, 4.5 YEARS | DrugDosageText | CC BY | 33401396 | 18,800,068 | 2021-01-01 |
What was the dosage of drug 'RITUXIMAB'? | The Role of Non-Selective TNF Inhibitors in Demyelinating Events.
The use of non-selective tumor necrosis factor (TNF) inhibitors is well known in the treatment of inflammatory diseases such as rheumatoid arthritis, Crohn's disease, and psoriasis. Its use in neurological disorders is limited however, due to rare advers... | UNK; (TWO?COURSE) | DrugDosageText | CC BY | 33401396 | 18,783,118 | 2021-01-01 |
What was the outcome of reaction 'Cognitive disorder'? | The Role of Non-Selective TNF Inhibitors in Demyelinating Events.
The use of non-selective tumor necrosis factor (TNF) inhibitors is well known in the treatment of inflammatory diseases such as rheumatoid arthritis, Crohn's disease, and psoriasis. Its use in neurological disorders is limited however, due to rare advers... | Recovered | ReactionOutcome | CC BY | 33401396 | 18,800,068 | 2021-01-01 |
What was the outcome of reaction 'Condition aggravated'? | The Role of Non-Selective TNF Inhibitors in Demyelinating Events.
The use of non-selective tumor necrosis factor (TNF) inhibitors is well known in the treatment of inflammatory diseases such as rheumatoid arthritis, Crohn's disease, and psoriasis. Its use in neurological disorders is limited however, due to rare advers... | Recovering | ReactionOutcome | CC BY | 33401396 | 18,749,761 | 2021-01-01 |
What was the outcome of reaction 'Demyelination'? | The Role of Non-Selective TNF Inhibitors in Demyelinating Events.
The use of non-selective tumor necrosis factor (TNF) inhibitors is well known in the treatment of inflammatory diseases such as rheumatoid arthritis, Crohn's disease, and psoriasis. Its use in neurological disorders is limited however, due to rare advers... | Recovering | ReactionOutcome | CC BY | 33401396 | 18,783,118 | 2021-01-01 |
What was the outcome of reaction 'Hemiparesis'? | The Role of Non-Selective TNF Inhibitors in Demyelinating Events.
The use of non-selective tumor necrosis factor (TNF) inhibitors is well known in the treatment of inflammatory diseases such as rheumatoid arthritis, Crohn's disease, and psoriasis. Its use in neurological disorders is limited however, due to rare advers... | Recovering | ReactionOutcome | CC BY | 33401396 | 18,800,068 | 2021-01-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Foetal death'. | Klebsiella pneumoniae Chorioamnionitis: An Underrecognized Cause of Preterm Premature Rupture of Membranes in the Second Trimester.
Klebsiella pneumoniae is a Gram-negative, rod-shaped bacterium, responsible for hospital and community acquired pneumonia, urinary tract and wound infections, and bloodstream dissemination... | AMOXICILLIN\CLAVULANIC ACID, AMPICILLIN, AZITHROMYCIN ANHYDROUS | DrugsGivenReaction | CC BY | 33401648 | 19,583,466 | 2021-01-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Foetal exposure during pregnancy'. | Klebsiella pneumoniae Chorioamnionitis: An Underrecognized Cause of Preterm Premature Rupture of Membranes in the Second Trimester.
Klebsiella pneumoniae is a Gram-negative, rod-shaped bacterium, responsible for hospital and community acquired pneumonia, urinary tract and wound infections, and bloodstream dissemination... | AMOXICILLIN\CLAVULANIC ACID, AMPICILLIN, AZITHROMYCIN ANHYDROUS | DrugsGivenReaction | CC BY | 33401648 | 19,583,466 | 2021-01-03 |
What was the administration route of drug 'AMOXICILLIN\CLAVULANIC ACID'? | Klebsiella pneumoniae Chorioamnionitis: An Underrecognized Cause of Preterm Premature Rupture of Membranes in the Second Trimester.
Klebsiella pneumoniae is a Gram-negative, rod-shaped bacterium, responsible for hospital and community acquired pneumonia, urinary tract and wound infections, and bloodstream dissemination... | Transplacental | DrugAdministrationRoute | CC BY | 33401648 | 19,583,466 | 2021-01-03 |
What was the administration route of drug 'AMPICILLIN'? | Klebsiella pneumoniae Chorioamnionitis: An Underrecognized Cause of Preterm Premature Rupture of Membranes in the Second Trimester.
Klebsiella pneumoniae is a Gram-negative, rod-shaped bacterium, responsible for hospital and community acquired pneumonia, urinary tract and wound infections, and bloodstream dissemination... | Transplacental | DrugAdministrationRoute | CC BY | 33401648 | 19,583,466 | 2021-01-03 |
What was the administration route of drug 'AZITHROMYCIN ANHYDROUS'? | Klebsiella pneumoniae Chorioamnionitis: An Underrecognized Cause of Preterm Premature Rupture of Membranes in the Second Trimester.
Klebsiella pneumoniae is a Gram-negative, rod-shaped bacterium, responsible for hospital and community acquired pneumonia, urinary tract and wound infections, and bloodstream dissemination... | Transplacental | DrugAdministrationRoute | CC BY | 33401648 | 19,583,466 | 2021-01-03 |
What was the outcome of reaction 'Foetal death'? | Klebsiella pneumoniae Chorioamnionitis: An Underrecognized Cause of Preterm Premature Rupture of Membranes in the Second Trimester.
Klebsiella pneumoniae is a Gram-negative, rod-shaped bacterium, responsible for hospital and community acquired pneumonia, urinary tract and wound infections, and bloodstream dissemination... | Fatal | ReactionOutcome | CC BY | 33401648 | 19,583,466 | 2021-01-03 |
What was the outcome of reaction 'Foetal exposure during pregnancy'? | Klebsiella pneumoniae Chorioamnionitis: An Underrecognized Cause of Preterm Premature Rupture of Membranes in the Second Trimester.
Klebsiella pneumoniae is a Gram-negative, rod-shaped bacterium, responsible for hospital and community acquired pneumonia, urinary tract and wound infections, and bloodstream dissemination... | Recovered | ReactionOutcome | CC BY | 33401648 | 19,583,466 | 2021-01-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Clostridium difficile colitis'. | Clostridium difficile appendicitis in an immunocompromised patient: a case report and review of the literature.
BACKGROUND
Clostridium difficile (C. difficile) is a common cause of infectious colitis in individuals with prior antibiotic or hospital exposure. Extraintestinal manifestations of C. difficile infections, ho... | CISPLATIN | DrugsGivenReaction | CC BY | 33402156 | 18,799,214 | 2021-01-05 |
What was the administration route of drug 'VANCOMYCIN'? | Clostridium difficile appendicitis in an immunocompromised patient: a case report and review of the literature.
BACKGROUND
Clostridium difficile (C. difficile) is a common cause of infectious colitis in individuals with prior antibiotic or hospital exposure. Extraintestinal manifestations of C. difficile infections, ho... | Oral | DrugAdministrationRoute | CC BY | 33402156 | 18,870,745 | 2021-01-05 |
What was the dosage of drug 'CISPLATIN'? | Clostridium difficile appendicitis in an immunocompromised patient: a case report and review of the literature.
BACKGROUND
Clostridium difficile (C. difficile) is a common cause of infectious colitis in individuals with prior antibiotic or hospital exposure. Extraintestinal manifestations of C. difficile infections, ho... | UNKNOWN | DrugDosageText | CC BY | 33402156 | 18,799,214 | 2021-01-05 |
What was the outcome of reaction 'Clostridium difficile colitis'? | Clostridium difficile appendicitis in an immunocompromised patient: a case report and review of the literature.
BACKGROUND
Clostridium difficile (C. difficile) is a common cause of infectious colitis in individuals with prior antibiotic or hospital exposure. Extraintestinal manifestations of C. difficile infections, ho... | Recovering | ReactionOutcome | CC BY | 33402156 | 18,799,214 | 2021-01-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Calcification of muscle'. | A severe case of thrombocytopenia, anasarca, fever, renal insufficiency or reticulin fibrosis, and organomegaly syndrome with myocardial and skeletal muscle calcification despite hypocalcemia: a case report.
BACKGROUND
TAFRO (thrombocytopenia, anasarca, fever, renal insufficiency or reticulin fibrosis, and organomegaly... | CALCIUM GLUCONATE, METHYLPREDNISOLONE, TOCILIZUMAB | DrugsGivenReaction | CC BY | 33402219 | 19,396,568 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myocardial calcification'. | A severe case of thrombocytopenia, anasarca, fever, renal insufficiency or reticulin fibrosis, and organomegaly syndrome with myocardial and skeletal muscle calcification despite hypocalcemia: a case report.
BACKGROUND
TAFRO (thrombocytopenia, anasarca, fever, renal insufficiency or reticulin fibrosis, and organomegaly... | CALCIUM GLUCONATE, METHYLPREDNISOLONE, TOCILIZUMAB | DrugsGivenReaction | CC BY | 33402219 | 19,396,568 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sinus node dysfunction'. | A severe case of thrombocytopenia, anasarca, fever, renal insufficiency or reticulin fibrosis, and organomegaly syndrome with myocardial and skeletal muscle calcification despite hypocalcemia: a case report.
BACKGROUND
TAFRO (thrombocytopenia, anasarca, fever, renal insufficiency or reticulin fibrosis, and organomegaly... | CALCIUM GLUCONATE, METHYLPREDNISOLONE, TOCILIZUMAB | DrugsGivenReaction | CC BY | 33402219 | 19,396,568 | 2021-01-06 |
What was the administration route of drug 'CALCIUM GLUCONATE'? | A severe case of thrombocytopenia, anasarca, fever, renal insufficiency or reticulin fibrosis, and organomegaly syndrome with myocardial and skeletal muscle calcification despite hypocalcemia: a case report.
BACKGROUND
TAFRO (thrombocytopenia, anasarca, fever, renal insufficiency or reticulin fibrosis, and organomegaly... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33402219 | 19,396,568 | 2021-01-06 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | A severe case of thrombocytopenia, anasarca, fever, renal insufficiency or reticulin fibrosis, and organomegaly syndrome with myocardial and skeletal muscle calcification despite hypocalcemia: a case report.
BACKGROUND
TAFRO (thrombocytopenia, anasarca, fever, renal insufficiency or reticulin fibrosis, and organomegaly... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33402219 | 19,396,568 | 2021-01-06 |
What was the dosage of drug 'METHYLPREDNISOLONE'? | A severe case of thrombocytopenia, anasarca, fever, renal insufficiency or reticulin fibrosis, and organomegaly syndrome with myocardial and skeletal muscle calcification despite hypocalcemia: a case report.
BACKGROUND
TAFRO (thrombocytopenia, anasarca, fever, renal insufficiency or reticulin fibrosis, and organomegaly... | PULSE THERAPY | DrugDosageText | CC BY | 33402219 | 19,396,568 | 2021-01-06 |
What was the outcome of reaction 'Calcification of muscle'? | A severe case of thrombocytopenia, anasarca, fever, renal insufficiency or reticulin fibrosis, and organomegaly syndrome with myocardial and skeletal muscle calcification despite hypocalcemia: a case report.
BACKGROUND
TAFRO (thrombocytopenia, anasarca, fever, renal insufficiency or reticulin fibrosis, and organomegaly... | Recovered | ReactionOutcome | CC BY | 33402219 | 19,396,568 | 2021-01-06 |
What was the outcome of reaction 'Myocardial calcification'? | A severe case of thrombocytopenia, anasarca, fever, renal insufficiency or reticulin fibrosis, and organomegaly syndrome with myocardial and skeletal muscle calcification despite hypocalcemia: a case report.
BACKGROUND
TAFRO (thrombocytopenia, anasarca, fever, renal insufficiency or reticulin fibrosis, and organomegaly... | Recovered | ReactionOutcome | CC BY | 33402219 | 19,396,568 | 2021-01-06 |
What was the outcome of reaction 'Sinus node dysfunction'? | A severe case of thrombocytopenia, anasarca, fever, renal insufficiency or reticulin fibrosis, and organomegaly syndrome with myocardial and skeletal muscle calcification despite hypocalcemia: a case report.
BACKGROUND
TAFRO (thrombocytopenia, anasarca, fever, renal insufficiency or reticulin fibrosis, and organomegaly... | Recovered | ReactionOutcome | CC BY | 33402219 | 19,396,568 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Concurrent BK polyomavirus, adenovirus and cytomegalovirus infections in a patient treated for chronic lymphocytic leukaemia.
A 58-year-old woman with chronic lymphocytic leukaemia (CLL) presented with 2 weeks of fever and haematuria following chemo-immunotherapy. CT scan showed thickening of her left urethra and bladd... | CIDOFOVIR, CYCLOPHOSPHAMIDE, FILGRASTIM, FLUDARABINE PHOSPHATE, HUMAN IMMUNOGLOBULIN G, PROBENECID, RITUXIMAB, SODIUM CHLORIDE, SULFAMETHOXAZOLE\TRIMETHOPRIM, VALACYCLOVIR HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33402369 | 19,066,566 | 2021-01-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Adenovirus infection'. | Concurrent BK polyomavirus, adenovirus and cytomegalovirus infections in a patient treated for chronic lymphocytic leukaemia.
A 58-year-old woman with chronic lymphocytic leukaemia (CLL) presented with 2 weeks of fever and haematuria following chemo-immunotherapy. CT scan showed thickening of her left urethra and bladd... | CIDOFOVIR, CYCLOPHOSPHAMIDE, FILGRASTIM, FLUDARABINE PHOSPHATE, HUMAN IMMUNOGLOBULIN G, PROBENECID, RITUXIMAB, SODIUM CHLORIDE, SULFAMETHOXAZOLE\TRIMETHOPRIM, VALACYCLOVIR HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33402369 | 19,066,566 | 2021-01-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cystitis haemorrhagic'. | Concurrent BK polyomavirus, adenovirus and cytomegalovirus infections in a patient treated for chronic lymphocytic leukaemia.
A 58-year-old woman with chronic lymphocytic leukaemia (CLL) presented with 2 weeks of fever and haematuria following chemo-immunotherapy. CT scan showed thickening of her left urethra and bladd... | CIDOFOVIR, CYCLOPHOSPHAMIDE, FILGRASTIM, FLUDARABINE PHOSPHATE, HUMAN IMMUNOGLOBULIN G, PROBENECID, RITUXIMAB, SODIUM CHLORIDE, SULFAMETHOXAZOLE\TRIMETHOPRIM, VALACYCLOVIR HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33402369 | 19,066,566 | 2021-01-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hydronephrosis'. | Concurrent BK polyomavirus, adenovirus and cytomegalovirus infections in a patient treated for chronic lymphocytic leukaemia.
A 58-year-old woman with chronic lymphocytic leukaemia (CLL) presented with 2 weeks of fever and haematuria following chemo-immunotherapy. CT scan showed thickening of her left urethra and bladd... | CIDOFOVIR, CYCLOPHOSPHAMIDE, FILGRASTIM, FLUDARABINE PHOSPHATE, HUMAN IMMUNOGLOBULIN G, PROBENECID, RITUXIMAB, SODIUM CHLORIDE, SULFAMETHOXAZOLE\TRIMETHOPRIM, VALACYCLOVIR HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33402369 | 19,066,566 | 2021-01-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypogammaglobulinaemia'. | Concurrent BK polyomavirus, adenovirus and cytomegalovirus infections in a patient treated for chronic lymphocytic leukaemia.
A 58-year-old woman with chronic lymphocytic leukaemia (CLL) presented with 2 weeks of fever and haematuria following chemo-immunotherapy. CT scan showed thickening of her left urethra and bladd... | CIDOFOVIR, CYCLOPHOSPHAMIDE, FILGRASTIM, FLUDARABINE PHOSPHATE, HUMAN IMMUNOGLOBULIN G, PROBENECID, RITUXIMAB, SODIUM CHLORIDE, SULFAMETHOXAZOLE\TRIMETHOPRIM, VALACYCLOVIR HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33402369 | 19,066,566 | 2021-01-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myelosuppression'. | Concurrent BK polyomavirus, adenovirus and cytomegalovirus infections in a patient treated for chronic lymphocytic leukaemia.
A 58-year-old woman with chronic lymphocytic leukaemia (CLL) presented with 2 weeks of fever and haematuria following chemo-immunotherapy. CT scan showed thickening of her left urethra and bladd... | CIDOFOVIR, CYCLOPHOSPHAMIDE, FILGRASTIM, FLUDARABINE PHOSPHATE, HUMAN IMMUNOGLOBULIN G, PROBENECID, RITUXIMAB, SODIUM CHLORIDE, SULFAMETHOXAZOLE\TRIMETHOPRIM, VALACYCLOVIR HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33402369 | 19,066,566 | 2021-01-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | Concurrent BK polyomavirus, adenovirus and cytomegalovirus infections in a patient treated for chronic lymphocytic leukaemia.
A 58-year-old woman with chronic lymphocytic leukaemia (CLL) presented with 2 weeks of fever and haematuria following chemo-immunotherapy. CT scan showed thickening of her left urethra and bladd... | CIDOFOVIR, DARBEPOETIN ALFA, FILGRASTIM, GANCICLOVIR, HUMAN IMMUNOGLOBULIN G, MEROPENEM, PROBENECID, VALGANCICLOVIR | DrugsGivenReaction | CC BY-NC | 33402369 | 18,752,790 | 2021-01-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pancytopenia'. | Concurrent BK polyomavirus, adenovirus and cytomegalovirus infections in a patient treated for chronic lymphocytic leukaemia.
A 58-year-old woman with chronic lymphocytic leukaemia (CLL) presented with 2 weeks of fever and haematuria following chemo-immunotherapy. CT scan showed thickening of her left urethra and bladd... | CIDOFOVIR, CYCLOPHOSPHAMIDE, FILGRASTIM, FLUDARABINE PHOSPHATE, HUMAN IMMUNOGLOBULIN G, PROBENECID, RITUXIMAB, SODIUM CHLORIDE, SULFAMETHOXAZOLE\TRIMETHOPRIM, VALACYCLOVIR HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33402369 | 19,066,566 | 2021-01-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Polyomavirus viraemia'. | Concurrent BK polyomavirus, adenovirus and cytomegalovirus infections in a patient treated for chronic lymphocytic leukaemia.
A 58-year-old woman with chronic lymphocytic leukaemia (CLL) presented with 2 weeks of fever and haematuria following chemo-immunotherapy. CT scan showed thickening of her left urethra and bladd... | CIDOFOVIR, CYCLOPHOSPHAMIDE, FILGRASTIM, FLUDARABINE PHOSPHATE, HUMAN IMMUNOGLOBULIN G, PROBENECID, RITUXIMAB, SODIUM CHLORIDE, SULFAMETHOXAZOLE\TRIMETHOPRIM, VALACYCLOVIR HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33402369 | 19,066,566 | 2021-01-05 |
What was the administration route of drug 'GANCICLOVIR'? | Concurrent BK polyomavirus, adenovirus and cytomegalovirus infections in a patient treated for chronic lymphocytic leukaemia.
A 58-year-old woman with chronic lymphocytic leukaemia (CLL) presented with 2 weeks of fever and haematuria following chemo-immunotherapy. CT scan showed thickening of her left urethra and bladd... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33402369 | 18,752,790 | 2021-01-05 |
What was the administration route of drug 'HUMAN IMMUNOGLOBULIN G'? | Concurrent BK polyomavirus, adenovirus and cytomegalovirus infections in a patient treated for chronic lymphocytic leukaemia.
A 58-year-old woman with chronic lymphocytic leukaemia (CLL) presented with 2 weeks of fever and haematuria following chemo-immunotherapy. CT scan showed thickening of her left urethra and bladd... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33402369 | 19,066,566 | 2021-01-05 |
What was the administration route of drug 'PROBENECID'? | Concurrent BK polyomavirus, adenovirus and cytomegalovirus infections in a patient treated for chronic lymphocytic leukaemia.
A 58-year-old woman with chronic lymphocytic leukaemia (CLL) presented with 2 weeks of fever and haematuria following chemo-immunotherapy. CT scan showed thickening of her left urethra and bladd... | Oral | DrugAdministrationRoute | CC BY-NC | 33402369 | 19,066,566 | 2021-01-05 |
What was the administration route of drug 'VALACYCLOVIR HYDROCHLORIDE'? | Concurrent BK polyomavirus, adenovirus and cytomegalovirus infections in a patient treated for chronic lymphocytic leukaemia.
A 58-year-old woman with chronic lymphocytic leukaemia (CLL) presented with 2 weeks of fever and haematuria following chemo-immunotherapy. CT scan showed thickening of her left urethra and bladd... | Oral | DrugAdministrationRoute | CC BY-NC | 33402369 | 19,066,566 | 2021-01-05 |
What was the administration route of drug 'VALGANCICLOVIR'? | Concurrent BK polyomavirus, adenovirus and cytomegalovirus infections in a patient treated for chronic lymphocytic leukaemia.
A 58-year-old woman with chronic lymphocytic leukaemia (CLL) presented with 2 weeks of fever and haematuria following chemo-immunotherapy. CT scan showed thickening of her left urethra and bladd... | Oral | DrugAdministrationRoute | CC BY-NC | 33402369 | 18,752,790 | 2021-01-05 |
What was the dosage of drug 'GANCICLOVIR'? | Concurrent BK polyomavirus, adenovirus and cytomegalovirus infections in a patient treated for chronic lymphocytic leukaemia.
A 58-year-old woman with chronic lymphocytic leukaemia (CLL) presented with 2 weeks of fever and haematuria following chemo-immunotherapy. CT scan showed thickening of her left urethra and bladd... | 250 MILLIGRAM, BID | DrugDosageText | CC BY-NC | 33402369 | 18,752,790 | 2021-01-05 |
What was the dosage of drug 'HUMAN IMMUNOGLOBULIN G'? | Concurrent BK polyomavirus, adenovirus and cytomegalovirus infections in a patient treated for chronic lymphocytic leukaemia.
A 58-year-old woman with chronic lymphocytic leukaemia (CLL) presented with 2 weeks of fever and haematuria following chemo-immunotherapy. CT scan showed thickening of her left urethra and bladd... | THREE TIMES AT 4 WEEK INTERVALS | DrugDosageText | CC BY-NC | 33402369 | 18,752,790 | 2021-01-05 |
What was the dosage of drug 'SODIUM CHLORIDE'? | Concurrent BK polyomavirus, adenovirus and cytomegalovirus infections in a patient treated for chronic lymphocytic leukaemia.
A 58-year-old woman with chronic lymphocytic leukaemia (CLL) presented with 2 weeks of fever and haematuria following chemo-immunotherapy. CT scan showed thickening of her left urethra and bladd... | 1 LT | DrugDosageText | CC BY-NC | 33402369 | 19,066,566 | 2021-01-05 |
What was the dosage of drug 'SULFAMETHOXAZOLE\TRIMETHOPRIM'? | Concurrent BK polyomavirus, adenovirus and cytomegalovirus infections in a patient treated for chronic lymphocytic leukaemia.
A 58-year-old woman with chronic lymphocytic leukaemia (CLL) presented with 2 weeks of fever and haematuria following chemo-immunotherapy. CT scan showed thickening of her left urethra and bladd... | ON MONDAY, TUESDAY AND WEDNESDAY EVERY WEEK | DrugDosageText | CC BY-NC | 33402369 | 19,066,566 | 2021-01-05 |
What was the dosage of drug 'VALACYCLOVIR HYDROCHLORIDE'? | Concurrent BK polyomavirus, adenovirus and cytomegalovirus infections in a patient treated for chronic lymphocytic leukaemia.
A 58-year-old woman with chronic lymphocytic leukaemia (CLL) presented with 2 weeks of fever and haematuria following chemo-immunotherapy. CT scan showed thickening of her left urethra and bladd... | 1000 MILLIGRAM DAILY; | DrugDosageText | CC BY-NC | 33402369 | 19,066,566 | 2021-01-05 |
What was the dosage of drug 'VALGANCICLOVIR'? | Concurrent BK polyomavirus, adenovirus and cytomegalovirus infections in a patient treated for chronic lymphocytic leukaemia.
A 58-year-old woman with chronic lymphocytic leukaemia (CLL) presented with 2 weeks of fever and haematuria following chemo-immunotherapy. CT scan showed thickening of her left urethra and bladd... | 450 MILLIGRAM, QD | DrugDosageText | CC BY-NC | 33402369 | 18,752,790 | 2021-01-05 |
What was the outcome of reaction 'Cystitis haemorrhagic'? | Concurrent BK polyomavirus, adenovirus and cytomegalovirus infections in a patient treated for chronic lymphocytic leukaemia.
A 58-year-old woman with chronic lymphocytic leukaemia (CLL) presented with 2 weeks of fever and haematuria following chemo-immunotherapy. CT scan showed thickening of her left urethra and bladd... | Recovered | ReactionOutcome | CC BY-NC | 33402369 | 19,066,566 | 2021-01-05 |
What was the outcome of reaction 'Cytomegalovirus infection'? | Concurrent BK polyomavirus, adenovirus and cytomegalovirus infections in a patient treated for chronic lymphocytic leukaemia.
A 58-year-old woman with chronic lymphocytic leukaemia (CLL) presented with 2 weeks of fever and haematuria following chemo-immunotherapy. CT scan showed thickening of her left urethra and bladd... | Recovered | ReactionOutcome | CC BY-NC | 33402369 | 19,066,566 | 2021-01-05 |
What was the outcome of reaction 'Hydronephrosis'? | Concurrent BK polyomavirus, adenovirus and cytomegalovirus infections in a patient treated for chronic lymphocytic leukaemia.
A 58-year-old woman with chronic lymphocytic leukaemia (CLL) presented with 2 weeks of fever and haematuria following chemo-immunotherapy. CT scan showed thickening of her left urethra and bladd... | Recovering | ReactionOutcome | CC BY-NC | 33402369 | 19,066,566 | 2021-01-05 |
What was the outcome of reaction 'Myelosuppression'? | Concurrent BK polyomavirus, adenovirus and cytomegalovirus infections in a patient treated for chronic lymphocytic leukaemia.
A 58-year-old woman with chronic lymphocytic leukaemia (CLL) presented with 2 weeks of fever and haematuria following chemo-immunotherapy. CT scan showed thickening of her left urethra and bladd... | Recovered | ReactionOutcome | CC BY-NC | 33402369 | 19,066,566 | 2021-01-05 |
What was the outcome of reaction 'Neutropenia'? | Concurrent BK polyomavirus, adenovirus and cytomegalovirus infections in a patient treated for chronic lymphocytic leukaemia.
A 58-year-old woman with chronic lymphocytic leukaemia (CLL) presented with 2 weeks of fever and haematuria following chemo-immunotherapy. CT scan showed thickening of her left urethra and bladd... | Recovered | ReactionOutcome | CC BY-NC | 33402369 | 18,752,790 | 2021-01-05 |
What was the outcome of reaction 'Pancytopenia'? | Concurrent BK polyomavirus, adenovirus and cytomegalovirus infections in a patient treated for chronic lymphocytic leukaemia.
A 58-year-old woman with chronic lymphocytic leukaemia (CLL) presented with 2 weeks of fever and haematuria following chemo-immunotherapy. CT scan showed thickening of her left urethra and bladd... | Recovered | ReactionOutcome | CC BY-NC | 33402369 | 19,066,566 | 2021-01-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intra-abdominal haemorrhage'. | A phase II study of gemcitabine, erlotinib and S-1 in patients with advanced pancreatic cancer.
Background: We evaluated the efficacy and safety of gemcitabine in combination with erlotinib and S-1 for the treatment of advanced pancreatic cancer. Methods: Chemotherapy-naïve patients with pathologically-proven locally a... | ERLOTINIB, GEMCITABINE HYDROCHLORIDE, GIMERACIL\OTERACIL\TEGAFUR | DrugsGivenReaction | CC BY | 33403047 | 18,745,930 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tumour rupture'. | A phase II study of gemcitabine, erlotinib and S-1 in patients with advanced pancreatic cancer.
Background: We evaluated the efficacy and safety of gemcitabine in combination with erlotinib and S-1 for the treatment of advanced pancreatic cancer. Methods: Chemotherapy-naïve patients with pathologically-proven locally a... | ERLOTINIB, GEMCITABINE HYDROCHLORIDE, GIMERACIL\OTERACIL\TEGAFUR | DrugsGivenReaction | CC BY | 33403047 | 18,745,930 | 2021 |
What was the administration route of drug 'ERLOTINIB'? | A phase II study of gemcitabine, erlotinib and S-1 in patients with advanced pancreatic cancer.
Background: We evaluated the efficacy and safety of gemcitabine in combination with erlotinib and S-1 for the treatment of advanced pancreatic cancer. Methods: Chemotherapy-naïve patients with pathologically-proven locally a... | Oral | DrugAdministrationRoute | CC BY | 33403047 | 18,745,930 | 2021 |
What was the administration route of drug 'GEMCITABINE HYDROCHLORIDE'? | A phase II study of gemcitabine, erlotinib and S-1 in patients with advanced pancreatic cancer.
Background: We evaluated the efficacy and safety of gemcitabine in combination with erlotinib and S-1 for the treatment of advanced pancreatic cancer. Methods: Chemotherapy-naïve patients with pathologically-proven locally a... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33403047 | 18,745,930 | 2021 |
What was the administration route of drug 'GIMERACIL\OTERACIL\TEGAFUR'? | A phase II study of gemcitabine, erlotinib and S-1 in patients with advanced pancreatic cancer.
Background: We evaluated the efficacy and safety of gemcitabine in combination with erlotinib and S-1 for the treatment of advanced pancreatic cancer. Methods: Chemotherapy-naïve patients with pathologically-proven locally a... | Oral | DrugAdministrationRoute | CC BY | 33403047 | 18,745,930 | 2021 |
What was the dosage of drug 'ERLOTINIB'? | A phase II study of gemcitabine, erlotinib and S-1 in patients with advanced pancreatic cancer.
Background: We evaluated the efficacy and safety of gemcitabine in combination with erlotinib and S-1 for the treatment of advanced pancreatic cancer. Methods: Chemotherapy-naïve patients with pathologically-proven locally a... | 100 MG, 1X/DAY | DrugDosageText | CC BY | 33403047 | 18,745,930 | 2021 |
What was the dosage of drug 'GEMCITABINE HYDROCHLORIDE'? | A phase II study of gemcitabine, erlotinib and S-1 in patients with advanced pancreatic cancer.
Background: We evaluated the efficacy and safety of gemcitabine in combination with erlotinib and S-1 for the treatment of advanced pancreatic cancer. Methods: Chemotherapy-naïve patients with pathologically-proven locally a... | 1000 MG/M2, CYCLIC (ON DAYS 1 AND 8 EVERY 3 WEEKS) | DrugDosageText | CC BY | 33403047 | 18,745,930 | 2021 |
What was the dosage of drug 'GIMERACIL\OTERACIL\TEGAFUR'? | A phase II study of gemcitabine, erlotinib and S-1 in patients with advanced pancreatic cancer.
Background: We evaluated the efficacy and safety of gemcitabine in combination with erlotinib and S-1 for the treatment of advanced pancreatic cancer. Methods: Chemotherapy-naïve patients with pathologically-proven locally a... | 30 MG/M2, 2X/DAY, ON DAYS 1?14 OF EACH CYCLE | DrugDosageText | CC BY | 33403047 | 18,745,930 | 2021 |
What was the outcome of reaction 'Intra-abdominal haemorrhage'? | A phase II study of gemcitabine, erlotinib and S-1 in patients with advanced pancreatic cancer.
Background: We evaluated the efficacy and safety of gemcitabine in combination with erlotinib and S-1 for the treatment of advanced pancreatic cancer. Methods: Chemotherapy-naïve patients with pathologically-proven locally a... | Fatal | ReactionOutcome | CC BY | 33403047 | 18,745,930 | 2021 |
What was the outcome of reaction 'Tumour rupture'? | A phase II study of gemcitabine, erlotinib and S-1 in patients with advanced pancreatic cancer.
Background: We evaluated the efficacy and safety of gemcitabine in combination with erlotinib and S-1 for the treatment of advanced pancreatic cancer. Methods: Chemotherapy-naïve patients with pathologically-proven locally a... | Fatal | ReactionOutcome | CC BY | 33403047 | 18,745,930 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Axonal neuropathy'. | Iatrogenic Kaposi's sarcoma in myasthenia gravis: learnings from two case reports.
BACKGROUND
Myasthenia gravis (MG) is an autoimmune neuromuscular disease whose treatment encompasses acetylcholinesterase inhibitors, oral steroids, and other immunosuppressants. Kaposi's sarcoma (KS) is a lymphangioproliferative disease... | AZATHIOPRINE, PACLITAXEL, PREDNISONE, PYRIDOSTIGMINE | DrugsGivenReaction | CC BY | 33404862 | 18,876,256 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diabetes mellitus'. | Iatrogenic Kaposi's sarcoma in myasthenia gravis: learnings from two case reports.
BACKGROUND
Myasthenia gravis (MG) is an autoimmune neuromuscular disease whose treatment encompasses acetylcholinesterase inhibitors, oral steroids, and other immunosuppressants. Kaposi's sarcoma (KS) is a lymphangioproliferative disease... | PREDNISONE | DrugsGivenReaction | CC BY | 33404862 | 18,817,174 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary embolism'. | Iatrogenic Kaposi's sarcoma in myasthenia gravis: learnings from two case reports.
BACKGROUND
Myasthenia gravis (MG) is an autoimmune neuromuscular disease whose treatment encompasses acetylcholinesterase inhibitors, oral steroids, and other immunosuppressants. Kaposi's sarcoma (KS) is a lymphangioproliferative disease... | AZATHIOPRINE, PACLITAXEL, PREDNISONE, PYRIDOSTIGMINE | DrugsGivenReaction | CC BY | 33404862 | 18,876,256 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Steroid diabetes'. | Iatrogenic Kaposi's sarcoma in myasthenia gravis: learnings from two case reports.
BACKGROUND
Myasthenia gravis (MG) is an autoimmune neuromuscular disease whose treatment encompasses acetylcholinesterase inhibitors, oral steroids, and other immunosuppressants. Kaposi's sarcoma (KS) is a lymphangioproliferative disease... | AZATHIOPRINE, PREDNISONE, PYRIDOSTIGMINE | DrugsGivenReaction | CC BY | 33404862 | 18,876,255 | 2021-05 |
What was the administration route of drug 'PACLITAXEL'? | Iatrogenic Kaposi's sarcoma in myasthenia gravis: learnings from two case reports.
BACKGROUND
Myasthenia gravis (MG) is an autoimmune neuromuscular disease whose treatment encompasses acetylcholinesterase inhibitors, oral steroids, and other immunosuppressants. Kaposi's sarcoma (KS) is a lymphangioproliferative disease... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33404862 | 18,876,256 | 2021-05 |
What was the administration route of drug 'PREDNISONE'? | Iatrogenic Kaposi's sarcoma in myasthenia gravis: learnings from two case reports.
BACKGROUND
Myasthenia gravis (MG) is an autoimmune neuromuscular disease whose treatment encompasses acetylcholinesterase inhibitors, oral steroids, and other immunosuppressants. Kaposi's sarcoma (KS) is a lymphangioproliferative disease... | Oral | DrugAdministrationRoute | CC BY | 33404862 | 18,817,174 | 2021-05 |
What was the outcome of reaction 'Axonal neuropathy'? | Iatrogenic Kaposi's sarcoma in myasthenia gravis: learnings from two case reports.
BACKGROUND
Myasthenia gravis (MG) is an autoimmune neuromuscular disease whose treatment encompasses acetylcholinesterase inhibitors, oral steroids, and other immunosuppressants. Kaposi's sarcoma (KS) is a lymphangioproliferative disease... | Recovering | ReactionOutcome | CC BY | 33404862 | 18,941,249 | 2021-05 |
What was the outcome of reaction 'Human herpesvirus 8 infection'? | Iatrogenic Kaposi's sarcoma in myasthenia gravis: learnings from two case reports.
BACKGROUND
Myasthenia gravis (MG) is an autoimmune neuromuscular disease whose treatment encompasses acetylcholinesterase inhibitors, oral steroids, and other immunosuppressants. Kaposi's sarcoma (KS) is a lymphangioproliferative disease... | Recovering | ReactionOutcome | CC BY | 33404862 | 18,876,256 | 2021-05 |
What was the outcome of reaction 'Pulmonary embolism'? | Iatrogenic Kaposi's sarcoma in myasthenia gravis: learnings from two case reports.
BACKGROUND
Myasthenia gravis (MG) is an autoimmune neuromuscular disease whose treatment encompasses acetylcholinesterase inhibitors, oral steroids, and other immunosuppressants. Kaposi's sarcoma (KS) is a lymphangioproliferative disease... | Recovered | ReactionOutcome | CC BY | 33404862 | 18,941,249 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | COVID-19 in Pediatric Granulomatosis with Polyangiitis.
The confirmed cases with COVID-19 in children account for just 1% of the overall confirmed cases. Severe COVID-19 in children is rare. Case Presentation: Our patient was 16 years old with a severe case of COVID-19 and did not survive due to the presence of Granulo... | ALLOPURINOL, ASPIRIN, FOLIC ACID, HYDROCORTISONE, HYDROXYCHLOROQUINE, LOPINAVIR, MEROPENEM, MYCOPHENOLIC ACID, RITONAVIR, VANCOMYCIN | DrugsGivenReaction | CC BY | 33406578 | 19,063,353 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | COVID-19 in Pediatric Granulomatosis with Polyangiitis.
The confirmed cases with COVID-19 in children account for just 1% of the overall confirmed cases. Severe COVID-19 in children is rare. Case Presentation: Our patient was 16 years old with a severe case of COVID-19 and did not survive due to the presence of Granulo... | ALLOPURINOL, ASPIRIN, FOLIC ACID, HYDROCORTISONE, HYDROXYCHLOROQUINE, LOPINAVIR, MEROPENEM, MYCOPHENOLIC ACID, RITONAVIR, VANCOMYCIN | DrugsGivenReaction | CC BY | 33406578 | 19,063,353 | 2021-01-04 |
What is the weight of the patient? | COVID-19 in Pediatric Granulomatosis with Polyangiitis.
The confirmed cases with COVID-19 in children account for just 1% of the overall confirmed cases. Severe COVID-19 in children is rare. Case Presentation: Our patient was 16 years old with a severe case of COVID-19 and did not survive due to the presence of Granulo... | 80 kg. | Weight | CC BY | 33406578 | 19,063,353 | 2021-01-04 |
What was the dosage of drug 'HYDROCORTISONE'? | COVID-19 in Pediatric Granulomatosis with Polyangiitis.
The confirmed cases with COVID-19 in children account for just 1% of the overall confirmed cases. Severe COVID-19 in children is rare. Case Presentation: Our patient was 16 years old with a severe case of COVID-19 and did not survive due to the presence of Granulo... | STRESS DOSE | DrugDosageText | CC BY | 33406578 | 19,063,353 | 2021-01-04 |
What was the outcome of reaction 'Drug ineffective for unapproved indication'? | COVID-19 in Pediatric Granulomatosis with Polyangiitis.
The confirmed cases with COVID-19 in children account for just 1% of the overall confirmed cases. Severe COVID-19 in children is rare. Case Presentation: Our patient was 16 years old with a severe case of COVID-19 and did not survive due to the presence of Granulo... | Fatal | ReactionOutcome | CC BY | 33406578 | 19,063,353 | 2021-01-04 |
What was the outcome of reaction 'Off label use'? | COVID-19 in Pediatric Granulomatosis with Polyangiitis.
The confirmed cases with COVID-19 in children account for just 1% of the overall confirmed cases. Severe COVID-19 in children is rare. Case Presentation: Our patient was 16 years old with a severe case of COVID-19 and did not survive due to the presence of Granulo... | Fatal | ReactionOutcome | CC BY | 33406578 | 19,063,353 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pruritus'. | Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase.
BACKGROUND
Evidence on whether the influenza vaccine could exacerbate immune-related adverse events, including myope... | INFLUENZA VIRUS VACCINE, IPILIMUMAB, NIVOLUMAB | DrugsGivenReaction | CC BY | 33406694 | 19,221,966 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary hypertension'. | Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase.
BACKGROUND
Evidence on whether the influenza vaccine could exacerbate immune-related adverse events, including myope... | INFLUENZA VIRUS VACCINE, IPILIMUMAB, NIVOLUMAB | DrugsGivenReaction | CC BY | 33406694 | 19,221,966 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Urticaria'. | Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase.
BACKGROUND
Evidence on whether the influenza vaccine could exacerbate immune-related adverse events, including myope... | INFLUENZA VIRUS VACCINE, IPILIMUMAB, NIVOLUMAB | DrugsGivenReaction | CC BY | 33406694 | 19,221,966 | 2021-01-04 |
What was the administration route of drug 'IPILIMUMAB'? | Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase.
BACKGROUND
Evidence on whether the influenza vaccine could exacerbate immune-related adverse events, including myope... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33406694 | 19,221,966 | 2021-01-04 |
What was the administration route of drug 'NIVOLUMAB'? | Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase.
BACKGROUND
Evidence on whether the influenza vaccine could exacerbate immune-related adverse events, including myope... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33406694 | 18,811,294 | 2021-01-04 |
What was the dosage of drug 'BEZAFIBRATE'? | Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase.
BACKGROUND
Evidence on whether the influenza vaccine could exacerbate immune-related adverse events, including myope... | 200 MILLIGRAM, QD | DrugDosageText | CC BY | 33406694 | 18,811,294 | 2021-01-04 |
What was the dosage of drug 'CALCITRIOL'? | Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase.
BACKGROUND
Evidence on whether the influenza vaccine could exacerbate immune-related adverse events, including myope... | 0.5 MICROGRAM, QD | DrugDosageText | CC BY | 33406694 | 18,811,294 | 2021-01-04 |
What was the dosage of drug 'URSODIOL'? | Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase.
BACKGROUND
Evidence on whether the influenza vaccine could exacerbate immune-related adverse events, including myope... | 200 MILLIGRAM, QD | DrugDosageText | CC BY | 33406694 | 18,811,294 | 2021-01-04 |
What was the outcome of reaction 'Myocarditis'? | Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase.
BACKGROUND
Evidence on whether the influenza vaccine could exacerbate immune-related adverse events, including myope... | Recovered | ReactionOutcome | CC BY | 33406694 | 18,811,294 | 2021-01-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaphylactic reaction'. | Circulatory collapse during wound closure in spine surgery with an unknown cause: a possible adverse effect of topical application of vancomycin?
Vancomycin (VCM) is effective in fighting Gram-positive bacteria related severe infections, and topical application of VCM powder is widely used in orthopedic surgery to prev... | VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33407142 | 18,839,984 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac arrest'. | Circulatory collapse during wound closure in spine surgery with an unknown cause: a possible adverse effect of topical application of vancomycin?
Vancomycin (VCM) is effective in fighting Gram-positive bacteria related severe infections, and topical application of VCM powder is widely used in orthopedic surgery to prev... | VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33407142 | 18,839,984 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Circulatory collapse'. | Circulatory collapse during wound closure in spine surgery with an unknown cause: a possible adverse effect of topical application of vancomycin?
Vancomycin (VCM) is effective in fighting Gram-positive bacteria related severe infections, and topical application of VCM powder is widely used in orthopedic surgery to prev... | VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33407142 | 18,839,984 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Coma'. | Circulatory collapse during wound closure in spine surgery with an unknown cause: a possible adverse effect of topical application of vancomycin?
Vancomycin (VCM) is effective in fighting Gram-positive bacteria related severe infections, and topical application of VCM powder is widely used in orthopedic surgery to prev... | VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33407142 | 18,839,984 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemorrhage intracranial'. | Circulatory collapse during wound closure in spine surgery with an unknown cause: a possible adverse effect of topical application of vancomycin?
Vancomycin (VCM) is effective in fighting Gram-positive bacteria related severe infections, and topical application of VCM powder is widely used in orthopedic surgery to prev... | VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33407142 | 18,822,543 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypoxic-ischaemic encephalopathy'. | Circulatory collapse during wound closure in spine surgery with an unknown cause: a possible adverse effect of topical application of vancomycin?
Vancomycin (VCM) is effective in fighting Gram-positive bacteria related severe infections, and topical application of VCM powder is widely used in orthopedic surgery to prev... | VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33407142 | 18,839,984 | 2021-01-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ventricular fibrillation'. | Circulatory collapse during wound closure in spine surgery with an unknown cause: a possible adverse effect of topical application of vancomycin?
Vancomycin (VCM) is effective in fighting Gram-positive bacteria related severe infections, and topical application of VCM powder is widely used in orthopedic surgery to prev... | VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33407142 | 18,839,984 | 2021-01-06 |
What was the administration route of drug 'VANCOMYCIN HYDROCHLORIDE'? | Circulatory collapse during wound closure in spine surgery with an unknown cause: a possible adverse effect of topical application of vancomycin?
Vancomycin (VCM) is effective in fighting Gram-positive bacteria related severe infections, and topical application of VCM powder is widely used in orthopedic surgery to prev... | Topical | DrugAdministrationRoute | CC BY | 33407142 | 18,839,984 | 2021-01-06 |
What was the outcome of reaction 'Anaphylactic reaction'? | Circulatory collapse during wound closure in spine surgery with an unknown cause: a possible adverse effect of topical application of vancomycin?
Vancomycin (VCM) is effective in fighting Gram-positive bacteria related severe infections, and topical application of VCM powder is widely used in orthopedic surgery to prev... | Recovered | ReactionOutcome | CC BY | 33407142 | 18,839,984 | 2021-01-06 |
What was the outcome of reaction 'Cardiac arrest'? | Circulatory collapse during wound closure in spine surgery with an unknown cause: a possible adverse effect of topical application of vancomycin?
Vancomycin (VCM) is effective in fighting Gram-positive bacteria related severe infections, and topical application of VCM powder is widely used in orthopedic surgery to prev... | Recovered | ReactionOutcome | CC BY | 33407142 | 18,839,984 | 2021-01-06 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.